English Only

What Do the Results of the FLOWER-MI Trial Indicate?

What Do the Results of the FLOWER-MI Trial Indicate?

The FLOWER-MI trial of ST-segment elevation MI patients with multivessel disease reported that after successful PCI of the infarct-related lesion, FFR-guided complete revascularization was associated with no difference in one-year mortality/MI/emergent revascularization rates compared with contrast-guided complete revascularization. FFR-guided revascularization, and the COMPARE-ACUTE trial reported the efficacy of FFR-guided complete revascularization in patients with ST-segment elevation MI.

We asked Dr. Hitoshi Matsuo, Gifu Heart Center, how we should interpret the results of the FLOWER-MI trial.

Please give us your honest opinion on the results of this study. I myself was hoping that FLOWER-MI...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

Long-term Outcomes in Diabetic Patients with FFR(-)/TCFA(+) - COMBINE OCT-FFR Trial, Experts Read
Long-term Outcomes in Diabetic Patients with FFR(-)/TCFA(+) - COMBINE OCT-FFR Trial, Experts Read
opinion
The Consideration of Antiplatelet Therapy after DES Implantation in HBR Patients from the MASTER DAPT Study
The Consideration of Antiplatelet Therapy after DES Implantation in HBR Patients from the MASTER DAPT Study
opinion
How Does the RIPCORD 2 Trial Differ from Previous Studies of FFR?
How Does the RIPCORD 2 Trial Differ from Previous Studies of FFR?
opinion
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Serial Change and Clinical Impact of Irregular Protrusion in Lesions With Chronic Coronary Syndrome
CCI
Serial Change and Clinical Impact of Irregular Protrusion in Lesions With Chronic Coronary Syndrome
Outcomes After CABG Compared With FFR-Guided PCI in Patients Presenting With Acute Coronary Syndrome
JACC Intervention
Outcomes After CABG Compared With FFR-Guided PCI in Patients Presenting With Acute Coronary Syndrome
[ Live video Part.2 ] Treatment Strategies for LAD Ostial CTO Lesions: Keys to Procedural Success
live video
[ Live video Part.2 ] Treatment Strategies for LAD Ostial CTO Lesions: Keys to Procedural Success
[ Live video Part.1 ] Optimal Treatment Strategies for Severe Calcified Lesions Using Advanced Debulking Techniques
live video
[ Live video Part.1 ] Optimal Treatment Strategies for Severe Calcified Lesions Using Advanced Debulking Techniques